Hepatitis/HIV Co-infection
Show Only Open Trials
1.
A5294: A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV/Hepatitis C Co-Infection
